iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
Illumina launched the BioInsight Platform on October 14, 2026, as a unified environment for genomic and multiomic analysis. It brings together analysis software, purpose-built artificial intelligence, and curated biological datasets behind one sign-on, with usage-based BioInsight Credits replacing traditional annual subscriptions. It is a software and data platform—not a sequencing instrument—with a free trial advertised by Illumina.
What Illumina announced
Illumina describes BioInsight as its first unified software environment for turning complex genomic and multiomic data into biological evidence. The platform is intended to give researchers, healthcare organizations, and biopharmaceutical companies one place to run analyses, apply AI models, and work with reusable biological data.
The launch consolidates capabilities that previously sat in separate products. Illumina says customers can use the platform to investigate disease biology, interpret variants, discover drug targets, support precision-medicine programs, and generate hypotheses from large studies. Rami Mehio, Illumina’s senior vice president and general manager of BioInsight, said the platform gives customers “one simple place to access the full breadth of our offerings across software, AI, and data,” while leaving room for additional capabilities in the future.
Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Scan for outdated or missing drivers - takes under a minuteDriver Scan →Is BioInsight a sequencer, a cloud service, or an AI product?
BioInsight is best understood as a software-and-data environment that can connect to sequencing workflows and host AI-enabled analysis. It does not replace a sequencing instrument. Instead, it links instrument output, secondary analysis, interpretation tools, AI models, and curated datasets.
#1 Best Overall
- TOP-SELLING CONSUMER DNA TEST: From your origins in over 3,600+ places around the world to the most connections to living relatives, no other DNA test kit delivers an experience as unique and interactive as AncestryDNA.
- YOUR DATA, YOUR CONTROL: We give you full control over your genetic information. You decide what to share, and with whom.
- DNA + TRAITS: Ever wondered where your freckles came from, or why you hate cilantro? AncestryDNA + Traits lets you discover 75+ genetic traits, allowing you to explore how your genes might have influenced a range of appearance, sensory, performance, nutrient, and other personal characteristics.
- A FEW SIMPLE STEPS: Simply activate your DNA kit online and return your saliva sample in the prepaid package to our state-of-the-art lab. Your results will be available online in roughly six weeks.
- ORIGINS AND INHERITANCE: AncestryDNA is the only DNA test that can show your origins results, DNA matches, and traits by each side of the family, without your parents taking a DNA test.
| Platform layer | What it does | Named capability |
|---|---|---|
| Workflow and analysis software | Processes and interprets genomic or multiomic results. | DRAGEN and Emedgene |
| Multiomic analysis | Analyzes and visualizes multimodal datasets at scale. | Connected Multiomics |
| Sequencer connectivity | Moves data from sequencing workflows into cloud analysis and can start downstream processing. | BaseSpace |
| Artificial intelligence | Predicts or prioritizes variant effects and supports biological foundation-model development. | BioInsight AI Lab, including SpliceAI2 for rare-disease research |
| Curated biological data | Provides harmonized, annotated, reusable datasets for comparison and contextual analysis. | BioInsight Data |
| Common access layer | Provides the shared environment and sign-on for the growing portfolio. | BioInsight Platform Core |
What is included
DRAGEN and Emedgene
DRAGEN supplies genomic data analysis, while Emedgene supports variant interpretation. Together, they address the path from sequence data to clinically or biologically relevant findings. Illumina lists both as part of the portfolio brought together under BioInsight.
Connected Multiomics
Connected Multiomics is Illumina’s cloud-based environment for analyzing and visualizing multiomic and multimodal data at scale. Illumina released it in January 2026 after an early-access period involving 40 users. Its inclusion gives BioInsight a dedicated workspace for studies that combine modalities rather than examining one assay in isolation.
BaseSpace connectivity
BaseSpace connects sequencing workflows to the cloud. Illumina says it can trigger downstream DRAGEN analysis without manual uploads, file transfers, or scripts. That automation is intended to reduce handoffs between an instrument run and secondary analysis, although the exact setup, data-retention rules, and supported configurations depend on an organization’s environment.
Rank #2
- TOP-SELLING CONSUMER DNA TEST: From your origins in over 3,600 places around the world to the most connections to living relatives, no other DNA test kit delivers an experience as unique and interactive as AncestryDNA.
- YOUR DATA, YOUR CONTROL: We give you full control over your genetic information. You decide what to share, and with whom.
- A FEW SIMPLE STEPS: Simply activate your DNA kit online and return your saliva sample in the prepaid package to our state-of-the-art lab. Your results will be available online in roughly six weeks.
- ORIGINS AND INHERITANCE: AncestryDNA provides more precise ancestral origins with greater geographic detail. Our innovative SideView technology takes your results even further by showing your origins and matches by parental side. *Some DNA features require an Ancestry subscription.
- BUILD YOUR FAMILY TREE: Combine what you learn from your DNA results with an Ancestry subscription and gain access to millions of family trees and the world's largest collection of online family history records. *Access to record collections varies depending on subscription level.
BioInsight AI Lab
The AI Lab develops models for variant-effect prediction, variant-effect prioritization, and biological foundation-model training. Illumina specifically highlights SpliceAI2 for rare-disease research. These models are intended to help researchers rank signals and focus laboratory or clinical review on variants most likely to matter; they do not eliminate the need for validation and domain expertise.
BioInsight Data
BioInsight Data covers curated datasets in oncology, rare disease, population health, and multiomics. Illumina characterizes the collections as harmonized, annotated, and reusable. The goal is to let teams compare studies, add context to their own findings, and form hypotheses without rebuilding data preparation for every project.
How a BioInsight workflow can run
- Generate or import data. A sequencing run or another multimodal experiment produces data that can be connected through BaseSpace or brought into the environment using an organization’s approved workflow.
- Run secondary analysis. DRAGEN or another supported analysis application processes the data. BaseSpace can initiate DRAGEN processing automatically, avoiding a manual transfer step.
- Interpret variants and signals. Emedgene and AI Lab models can help evaluate variant effects or prioritize candidates for further review.
- Add biological context. Researchers can compare results with BioInsight Data collections spanning oncology, rare disease, population health, and multiomics.
- Develop and test hypotheses. Findings can feed disease-biology studies, target-discovery work, precision-medicine investigations, or additional model development, subject to the team’s validation and governance requirements.
Who BioInsight is designed for
Research groups
Academic and independent research teams can use the combined analysis, AI, and data layers to examine rare-disease variants, compare cohorts, or explore multimodal biology without assembling every component separately.
Rank #3
- ABOUT THE TEST: The Genetrace DNA Paternity Test helps families conclusively determine if a man is the true father of a child.
- NO HIDDEN FEES: Kit includes all lab fees and sample return costs to test one (1) child and one (1) potential father.
- FAST RESULTS: Get secure, confidential results within 1-2 business days after testing begins. We'll keep you updated every step of the way.
- EASY SAMPLE COLLECTION: No needles, no blood, no doctors. Collect your samples with our easy-to-use mouth swabs, then return them to the lab with the provided prepaid return envelope. It's quick, easy & painless.
- ACCURATE & RELIABLE: Up to 27 genetic markers analyzed for over 99.999% accuracy. All tests performed TWICE in our AABB, ISO 17025 & CLIA accredited laboratory.
Healthcare organizations
Healthcare users are a stated audience for workflows such as variant interpretation and precision medicine. Any clinical deployment still requires the organization to assess regulatory status, validation, access controls, auditability, and local clinical governance; the launch announcement does not establish approval for a particular diagnostic use.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Biopharma companies
Biopharma teams are positioned to use the platform for disease-biology analysis, drug-target discovery, and large data projects. Illumina also cites strategic partnerships for AI-tool development and support for national or industry-scale datasets.
BioInsight Credits, pricing, and the free trial
Illumina says BioInsight uses usage-based BioInsight Credits instead of traditional annual subscriptions. Credits are intended to let customers adopt only the capabilities relevant to a current project while evaluating additional technologies later. The launch materials advertise a free-trial signup.
Rank #4
- MAP YOUR ORIGINS ACROSS 5,000+ REGIONS: Ancestry Composition breaks down your ethnicity across 5,000+ geographic regions worldwide, the most detailed ancestry breakdown of any consumer DNA service. Ancestry Timeline estimates how many generations ago your most recent ancestor from each population lived.
- FIND LIVING RELATIVES: Opt in to DNA Relatives to see up to 1,500 people in the 23andMe database who share DNA with you, from close family to distant cousins, and message them directly. Your Family Tree builds itself automatically based on your DNA.
- DISCOVER WHAT MAKES YOU UNIQUE: See how your DNA may influence physical features, sensory preferences, and habits across 30+ traits, including cilantro taste aversion to hair texture to deep sleep.
- TRACE ANCIENT MIGRATIONS: Maternal and Paternal Haplogroup reports follow your ancestors' migration paths across continents over thousands of years (paternal haplogroup requires a Y chromosome). Find out how much of your ancestry can be traced back to the Neanderthals.
- PRIVATE BY DESIGN: Your DNA data is encrypted, protected, and always under your control. Enhanced security measures are implemented to keep your information safe. Subject to 23andMe’s Terms of Service and Privacy Statement at 23andMe online.
Illumina has not disclosed credit prices, conversion rates, minimum purchases, expiration rules, storage charges, or the precise limits of the trial in the launch information. Organizations should request a current rate card and clarify whether compute, data storage, model usage, support, and collaboration features consume credits separately. Because the model is usage-based, budgeting depends on sample volume, workflow frequency, data retention, and the applications selected.
Why Illumina created BioInsight
Illumina established the BioInsight business in 2025 in response to the growing difficulty of interpreting large, complex multiomic datasets. Its stated priorities include scalable multimodal analysis, large national and industry data projects, private and secure access to research data, and partnerships to develop AI tools. The platform is the product-level expression of that strategy: combine computation, models, and curated data instead of treating them as disconnected purchases.
The Tool Desk
Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Performance claims and evidence limits
Illumina’s regional product page says DRAGEN can analyze a 30× whole human genome in under 25 minutes and says genetically supported drug targets have 2.6 times higher approval rates. Those are Illumina product-page claims, not independent benchmarks or a guarantee for every sample, configuration, or drug-development program. Actual speed depends on workflow settings, infrastructure, input data, and the analysis being run.
Best Value
- About HomePaternity: This DNA test will conclusively determine if a man is the biological father of a child using a simple at-home kit including cheek swabs from the father and child.
- Fast Results: Your kit includes Overnight FedEx return to the lab and results will be available within 1-2 days after your sample arrives, in our secure online portal.
- Over 99.999% Confidence: With up to 34 genetic markers examined, we confirm paternity with the highest accuracy, typically 99.999%+. Tests are run twice in our lab, which has obtained over 6 certifications.
- Easy Sample Collection: Collect your samples with mouth swabs, then return in the pre-paid Overnight mailer. Includes testing for 1 child and 1 possible father; can add more participants after kit registration.
- Internal Lab: With over 25 years of experience and over 20 million tests performed, we don’t use third-party labs.
The launch materials also do not provide independent head-to-head comparisons, customer-outcome studies, detailed security certifications, or a complete description of partner APIs. Prospective users should verify reproducibility, model explainability, data provenance, deployment options, and governance controls in a technical and contractual review.
Questions to resolve before adoption
- Which assays, file formats, instruments, and existing pipelines can connect directly?
- How are private datasets isolated, encrypted, retained, deleted, and audited?
- What provenance is attached to curated datasets and AI-generated prioritizations?
- Can teams export intermediate files, final results, and analysis metadata if they leave the service?
- How are BioInsight Credits metered across compute, storage, applications, and AI models?
- What validation evidence and human-review controls are available for rare-disease or clinical workflows?
- Which APIs, partner tools, and standard-compute deployment choices are supported?
The practical takeaway
BioInsight’s significance is organizational as much as technical: Illumina is packaging sequencing connectivity, genomic analysis, multiomics, AI, and curated data as one usage-based platform. It may simplify complex research workflows, but buyers still need to validate performance, governance, interoperability, and total credit consumption for their own workloads.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
